Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)
{{output}}
Introduction: Activin receptor-like kinase 5 (ALK5) is a pivotal component of the transforming growth factor β (TGF-β) signaling pathway. Currently, 10 ALK5 inhibitors are under clinical investigation, with numerous others in p... ...
